C T Vallejo
Overview
Explore the profile of C T Vallejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Machiavelli M, Salum G, Perez J, Ortiz E, Romero A, Bologna F, et al.
Am J Clin Oncol
. 2004 Apr;
27(2):149-54.
PMID: 15057154
The purpose of this report is to evaluate the efficacy and toxicity (Tx) of a double modulation of 5-fluorouracil (5-FU) by trimetrexate (TMTX) and leucovorin (LV) in patients with advanced...
2.
Vallejo C, Perez J, Dominguez M, Leone B, Machiavelli M, Lacava J, et al.
Am J Clin Oncol
. 2000 Oct;
23(5):481-6.
PMID: 11039508
A phase II trial was performed to assess the efficacy and toxicity of a combination of ifosfamide (IFX), cisplatin (CDDP), and vinorelbine (VNB) as neoadjuvant chemotherapy (NAC) for untreated advanced...
3.
Biochemical modulation of 5-fluorouracil by methotrexate in patients with advanced gastric carcinoma
Perez J, Lacava J, Dominguez M, Rodriguez R, Barbieri M, Ortiz E, et al.
Am J Clin Oncol
. 1998 Oct;
21(5):452-7.
PMID: 9781598
A phase II trial was conducted to evaluate the efficacy and toxicity of a modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) (with leucovorin (LV) rescue) as first-line chemotherapy in patients...
4.
Perez J, Lacava J, Dominguez M, Rodriguez R, Barbieri M, Romero Acuna L, et al.
J Interferon Cytokine Res
. 1998 Sep;
18(8):565-9.
PMID: 9726437
A phase II trial was carried out by the Grupo Oncologico Cooperativo del Sur (G.O.C.S.) to assess the efficacy and toxicity of a biochemical modulation of 5-fluorouracil (5-FU) by i.v....
5.
Machiavelli M, Romero A, Perez J, Lacava J, Dominguez M, Rodriguez R, et al.
Cancer J Sci Am
. 1998 Apr;
4(2):125-31.
PMID: 9554929
Purpose: The prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy was assessed in patients with noninflammatory locally advanced breast carcinoma. Patients And...
6.
Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, et al.
Am J Clin Oncol
. 1998 Mar;
21(1):94-8.
PMID: 9499269
A phase II trial was performed to evaluate the efficacy and toxicity of a double modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) and L-leucovorin (L-LV) in patients with advanced recurrent...
7.
Lacava J, Leone B, Machiavelli M, Romero A, Perez J, Elem Y, et al.
J Clin Oncol
. 1997 Feb;
15(2):604-9.
PMID: 9053483
Purpose: To evaluate the efficacy and toxicity of vinorelbine (VNB) as single-agent neoadjuvant chemotherapy in advanced cervical carcinoma (ACC). Patients And Methods: Between December 1993 and October 1995, 43 untreated...
8.
Leone B, Vallejo C, Romero A, Perez J, Cuevas M, Lacava J, et al.
J Clin Oncol
. 1996 Nov;
14(11):2993-9.
PMID: 8918497
Purpose: To evaluate the efficacy and toxicity of the combination of ifosfamide (IFX) and vinorelbine (VNB) as first-line chemotherapy in metastatic breast cancer (MBC). Patients And Methods: Between August 1993...
9.
Lacava J, Ferreyra R, Leone B, Losada C, Elem Y, Vallejo C
Cancer J Sci Am
. 1996 Jan;
2(1):46-51.
PMID: 9166498
Purpose: We conducted this study to evaluate the efficacy and toxicity of fractionated high-dose cisplatin as neoadjuvant organ-preserving chemotherapy, followed by definitive radiotherapy, for untreated and advanced squamous cell carcinoma...
10.
Vallejo C, RABINOVICH M, Perez J, Rodriguez R, Machiavelli M, Leone B, et al.
Am J Clin Oncol
. 1995 Jun;
18(3):185-8.
PMID: 7747703
From March 1991 to October 1992, 41 patients with advanced non-small cell lung cancer (NSCLC) (20 stage IIIB and 21 stage IV) received a regimen consisting of cisplatin (CP) 100...